Alyglo
NDC 61476-104, Human immunoglobulin G, liquid, from GC Biopharma Corp..
- Product NDC
- 61476-104
- Status
- Listed
- Labeler
- GC Biopharma Corp.
- Dosage form
- LIQUID
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125743
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61476-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HUMAN IMMUNOGLOBULIN G100 mg/mL
Pharmacologic classes
Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61476-104-05 | 61476010405 | 1 VIAL, GLASS in 1 CARTON (61476-104-05) / 50 mL in 1 VIAL, GLASS (61476-104-01) |
| 61476-104-10 | 61476010410 | 1 VIAL, GLASS in 1 CARTON (61476-104-10) / 100 mL in 1 VIAL, GLASS (61476-104-02) |
| 61476-104-20 | 61476010420 | 1 VIAL, GLASS in 1 CARTON (61476-104-20) / 200 mL in 1 VIAL, GLASS (61476-104-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61476-104
Use it
Look up 61476-104 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61476-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61476-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.